Department of Pathology and Immunology, Baylor College of Medicine, Houston, United States; Department of Neuroscience, Baylor College of Medicine, Houston, United States; Jan and Dan Duncan Neurological Research Institute of Texas Children's Hospital, Houston, United States
Joshua J White
Department of Pathology and Immunology, Baylor College of Medicine, Houston, United States; Department of Neuroscience, Baylor College of Medicine, Houston, United States; Jan and Dan Duncan Neurological Research Institute of Texas Children's Hospital, Houston, United States
Department of Pathology and Immunology, Baylor College of Medicine, Houston, United States; Jan and Dan Duncan Neurological Research Institute of Texas Children's Hospital, Houston, United States
Department of Pathology and Immunology, Baylor College of Medicine, Houston, United States; Department of Neuroscience, Baylor College of Medicine, Houston, United States; Jan and Dan Duncan Neurological Research Institute of Texas Children's Hospital, Houston, United States
Tao Lin
Department of Pathology and Immunology, Baylor College of Medicine, Houston, United States; Jan and Dan Duncan Neurological Research Institute of Texas Children's Hospital, Houston, United States
Department of Pathology and Immunology, Baylor College of Medicine, Houston, United States; Department of Neuroscience, Baylor College of Medicine, Houston, United States; Jan and Dan Duncan Neurological Research Institute of Texas Children's Hospital, Houston, United States; Development, Disease Models & Therapeutics Graduate Program, Baylor College of Medicine, Houston, United States
Tremor is currently ranked as the most common movement disorder. The brain regions and neural signals that initiate the debilitating shakiness of different body parts remain unclear. Here, we found that genetically silencing cerebellar Purkinje cell output blocked tremor in mice that were given the tremorgenic drug harmaline. We show in awake behaving mice that the onset of tremor is coincident with rhythmic Purkinje cell firing, which alters the activity of their target cerebellar nuclei cells. We mimic the tremorgenic action of the drug with optogenetics and present evidence that highly patterned Purkinje cell activity drives a powerful tremor in otherwise normal mice. Modulating the altered activity with deep brain stimulation directed to the Purkinje cell output in the cerebellar nuclei reduced tremor in freely moving mice. Together, the data implicate Purkinje cell connectivity as a neural substrate for tremor and a gateway for signals that mediate the disease.